HERTFORDSHIRE, England, and PITTSBURGH, May 18, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced four scientific abstracts from the Wixela™ Inhub™ ...

HERTFORDSHIRE, England and PITTSBURGH, March 10, 2020 /CNW/ -- Mylan Pharmaceuticals ULC today announced the launch of Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the ...

wixela-product-image Mylan plans to make Wixela Inhub available in 3 strengths: 100mcg/50mcg, 250mcg/50mcg, and 500mcg/50mcg. Wixela Inhub combines fluticasone propionate, a synthetic corticosteroid, ...

Mylan N.V. MYL received a significant boost when the FDA approved its generic version of GlaxoSmithKline's GSK Advair Diskus - Wixela Inhub - following a few setbacks. Notably, this is the first ...

wixela-product-image Wixela Inhub (fluticasone propionate and salmeterol inhalation powder), the first substitutable generic of Advair Diskus (GlaxoSmithKline), has been made available by Mylan Mylan ...

1. Wixela Inhub is Mylan’s generic version of Advair, an asthma treatment made by GlaxoSmithKline. 2. Tosymra is a sumatriptan nasal spray used to treat migraines in adults. 3. Imbruvica in ...

March 10 (Reuters) - Mylan NV: * MYLAN PHARMACEUTICALS ULC LAUNCHES WIXELA® INHUB® (FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER, USP), THE FIRST AVAILABLE BIOEQUIVALENT ALTERNATIVE TO ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. NEW YORK ...

Please provide your email address to receive an email when new articles are posted on . For approval, generic fluticasone-salmeterol was required to be tested in only patients with asthma, not COPD.

LONDON (Alliance News) - Shares in Consort Medical PLC fell early Tuesday after the drug delivery company warned that delays to Mylan NV's Wixela inhaler for lung disease treatment will hit annual ...

The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan's version in three strengths for ages ...

The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan’s version in three strengths for ages ...